Robot maker · registered
Bioliberty
Bioliberty develops the Lifeglov, a soft robotic exoskeleton glove for post-stroke hand rehabilitation. The device uses pneumatic actuation to assist flexion and extension of the digits, guided by a therapy software platform called Lifehub that tracks therapy frequency, duration, and patient outcomes. The company launched the Lifehub Clinic system in May 2025 with real-world clinical data from a September 2024-December 2025 study. Bioliberty opened a US headquarters in Boston in 2025 and raised £7.7M in 2026 backed by Old College Capital.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
Lifeglov
- Soft robotic exoskeleton glove for upper extremity stroke rehabilitation with Lifehub clinical analytics platform
Pneumatically actuated soft exoskeleton assisting hand open/close motion for stroke survivors; paired with gamified therapy software
Claim source
Lifehub Clinic
- No specifications on file.
Deployment log
Announced and cited only
Funding history
Publicly announced rounds
Series A
Round sourceCompany timeline
Milestones and announcements
Source ledger
5 unique public sources